Search research articles
Contact Us
Filters
Showing results (221-230 of 785) with videos related to
Page
of 79
Sort By:
Frontiers in Pharmacology
|
February 11, 2022
Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
Sok Cin Tye, Sieta T de Vries, Christoph Wanner, et al.
Diabetes, Obesity & Metabolism
|
December 15, 2021
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non-Asian populations of the EMPA-REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease
Kohei Kaku, Christoph Wanner, Stefan D Anker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 15, 2011
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry
Martin Wagner, David Ansell, David M Kent, et al.
Atherosclerosis
|
October 24, 2007
Transmission of oxLDL-derived lipid peroxide radicals into membranes of vascular cells is the main inducer of oxLDL-mediated oxidative stress
Thomas E Hansen-Hagge, Elke Baumeister, Tanja Bauer, et al.
Journal of Diabetes and Its Complications
|
October 18, 2023
Shifts in KDIGO CKD risk groups with empagliflozin: Kidney-protection from SGLT2 inhibition across the spectrum of risk
Robert Weingold, Bernard Zinman, Michaela Mattheus, et al.
Artificial Organs
|
April 23, 2015
Pharmacokinetics of Certoparin During In Vitro and In Vivo Dialysis
Detlef H Krieter, Susanne Fink, Oliver Dorsch, et al.
Nephron
|
August 22, 2021
Comparison of Static and Dynamic Baseline Creatinine Surrogates for Defining Acute Kidney Injury
David G Warnock, Javier A Neyra, Etienne Macedo, et al.
Diabetes, Obesity & Metabolism
|
September 24, 2021
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial
João Pedro Ferreira, Silvio E Inzucchi, Michaela Mattheus, et al.
Kidney International
|
October 10, 2002
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage?
Peter Stenvinkel, Christoph Wanner, Thomas Metzger, et al.
European Journal of Heart Failure
|
July 28, 2011
Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
Christiane Drechsler, Andreas Meinitzer, Stefan Pilz, et al.
Page
of 79
Search research articles
Search
Showing results (221-230 of 785) with videos related to
Sort By:
Page
of 79
Frontiers in Pharmacology
|
February 11, 2022
Prediction of the Effects of Empagliflozin on Cardiovascular and Kidney Outcomes Based on Short-Term Changes in Multiple Risk Markers
Sok Cin Tye, Sieta T de Vries, Christoph Wanner, et al.
Diabetes, Obesity & Metabolism
|
December 15, 2021
The effect of empagliflozin on the total burden of cardiovascular and hospitalization events in the Asian and non-Asian populations of the EMPA-REG OUTCOME trial of patients with type 2 diabetes and cardiovascular disease
Kohei Kaku, Christoph Wanner, Stefan D Anker, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 15, 2011
Predicting mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry
Martin Wagner, David Ansell, David M Kent, et al.
Atherosclerosis
|
October 24, 2007
Transmission of oxLDL-derived lipid peroxide radicals into membranes of vascular cells is the main inducer of oxLDL-mediated oxidative stress
Thomas E Hansen-Hagge, Elke Baumeister, Tanja Bauer, et al.
Journal of Diabetes and Its Complications
|
October 18, 2023
Shifts in KDIGO CKD risk groups with empagliflozin: Kidney-protection from SGLT2 inhibition across the spectrum of risk
Robert Weingold, Bernard Zinman, Michaela Mattheus, et al.
Artificial Organs
|
April 23, 2015
Pharmacokinetics of Certoparin During In Vitro and In Vivo Dialysis
Detlef H Krieter, Susanne Fink, Oliver Dorsch, et al.
Nephron
|
August 22, 2021
Comparison of Static and Dynamic Baseline Creatinine Surrogates for Defining Acute Kidney Injury
David G Warnock, Javier A Neyra, Etienne Macedo, et al.
Diabetes, Obesity & Metabolism
|
September 24, 2021
Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA-REG OUTCOME trial
João Pedro Ferreira, Silvio E Inzucchi, Michaela Mattheus, et al.
Kidney International
|
October 10, 2002
Inflammation and outcome in end-stage renal failure: does female gender constitute a survival advantage?
Peter Stenvinkel, Christoph Wanner, Thomas Metzger, et al.
European Journal of Heart Failure
|
July 28, 2011
Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
Christiane Drechsler, Andreas Meinitzer, Stefan Pilz, et al.
Page
of 79